With an eye on future pandemics, GSK will help set up 12 European countries for the possibility of an influenza pandemic

In that vein, GSK is helping 12 European countries prepare for a potential future influenza pandemic. The company agreed to supply its pandemic influenza vaccine Adjupanrix to these countries through a framework contract it signed with the European Commission’s Health Emergency Preparedness and Response Authority (HERA) to reserve future production and supply of 85 million doses of the vaccine.